Share-based Payment Arrangement, Expense of Tevogen Bio Holdings Inc. from 31 Mar 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tevogen Bio Holdings Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2024 to 30 Sep 2025.
  • Tevogen Bio Holdings Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $3,244,917, a 2.5% decline year-over-year.
  • Tevogen Bio Holdings Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $20,737,967.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)

Tevogen Bio Holdings Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $20,737,967 $3,244,917 -$82,734 -2.5% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $20,820,701 $3,239,333 -$902,887 -22% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $21,723,588 $7,292,701 -$19,040,548 -72% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $40,764,136 $6,961,016 01 Oct 2024 31 Dec 2024 10-K 02 Apr 2025 2024 FY
Q3 2024 $3,327,651 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $4,142,220 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $26,333,249 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1

Tevogen Bio Holdings Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $40,764,136 01 Jan 2024 31 Dec 2024 10-K 02 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.